Chapter 676: Tian Jiajun

The arrival of the Lasker Award for Clinical Medicine made Tian Lu feel a little surprised.

In the past few years, except for some major research groups and neurosurgical research under his direct leadership, Tian Lu has a little feeling of slowly retreating into the background, after all, all the work is done by his subordinates, and he sometimes just provides an idea, and he has to count it all on his head, Tian Lu is a little embarrassed, of course, there is no need for that.

Therefore, the nomination for the Lasker Award for Clinical Medicine is, of course, because of the first epilepsy surgical research that began that year.

In fact, the influence of standardized diagnosis and treatment of neurosurgery is greater, but relatively speaking, the time is too short for any major award to be awarded. This is a large clinical study that will last for at least one or two decades, and the current accumulation is not enough.

However, in the case of epilepsy surgery, the scale of one project is much smaller, and the other is that the clinical cooperation has been nearly 11 years, and with the publication of the two books "Epilepsy Surgery" and "Epilepsy", it is a matter of course to win the award.

So after a lapse of six years, Taro was nominated for the Lasker Award again!

After winning the Nobel Prize, if you look at the Lasker Prize again, you will definitely not be so excited anyway, but that night Tian Lu still forcefully squeezed out Feng Lin's plan to invite guests, and settled the account happily.

Preparing the application materials is familiar with the road and has no impact on the daily work of Tian Lu.

All aspects of the work are being carried out in an orderly manner, although the institute has a huge investment from the state and Beijing Normal University. However, the total amount of funds is almost negligible compared with Future Biology, so Tian Lu did not assign them many tasks, focusing on some important basic theoretical research in neurobiology, but after independently owning a Future Biology Building, the Institute still carried out a small-scale expansion, recruited many outstanding graduates, and began another round of accumulation of strength.

The same is true for neurosurgery.

What continues to maintain a high-speed development trend is still the future of biology.

According to the plan report submitted by Qian Lele at the beginning of the year, the number of new recruits in the whole year of 2027 will reach 1,500. However, the majority of laboratory technicians will be in the majority. Make up for the gap caused by the massive expansion of scientific researchers in the previous two years. Of course, if more very good scientific researchers join, Qian Lele will definitely not refuse, it is nothing more than to let the shortage of experimental technicians continue to exist.

Future creatures now. Definitely have the confidence to raise so many people.

According to Tian Lu's estimates for drug R&D and device consumables R&D departments. Qian Lele has long estimated the revenue figure of Future Biotech in 2027. In addition to the sales share of various multinational giants will continue to grow to more than 1.5 billion US dollars, even if all the newly developed patents are still transferred to domestic companies, and many of them will even be handed over to Kyoto Pharmaceutical. But it can still guarantee at least 20 billion Chinese dollars in cash income!

It's just that this total of 30 billion Chinese dollars is definitely no problem to maintain the operation of future creatures and ensure the implementation of follow-up projects of the scientific research base!

What's more, six years after winning Kyoto Medicine, Qian Lele finally saw a bright future!

Kyoto Medicine's antidepressant drugs should be on the market in the middle of the year according to the plan, and the funds invested by Future Biology have ensured the follow-up research and development and experiments of several new drugs. After all, from the very beginning, Kyoto Medicine has designed its experiments in full accordance with FDA standards, and there is no reason why it cannot pass.

In this case, there is no suspense about the global listing!

In addition, after very detailed and serious clinical trials, the full launch of hemostatic gel was also at the end of the year

In the past few years, half of the large amount of funds obtained by Kyoto Medicine has been used to establish marketing channels in several major countries and regions, of which the United States is naturally the top priority! The sales of psychotropic drugs in the United States have always been at the top of the world, and Kyoto Medicine must have spent a lot of effort.

There is also Great Wall Pharmaceutical, drugs for drug rehabilitation and smoking cessation will also be available at the end of the year or next year.

There is also the Franskes Group, which still owes $3.3 billion to Future Biotech, and anti-schizophrenic drugs should also be on the market in the next two years, so when the time comes, the $2 billion after the listing, and the $1.3 billion after the listing three years later, will definitely be delivered to Future Biotech before 2030!

If you calculate it this way, as long as the future biology will no longer launch too big projects, just rely on more and more sales shares in the future, and it will not be a problem to develop rapidly for seven or eight years!

Even when necessary, Lantian Company and Happy Bio can become a supplementary source of biological funds in the future!

The listing of Lantian Company and Happy Creature is not a whim of Tian Lu for a while, but the result of careful calculation. In Tian Lu's view, if it is listed now, there should be a high-speed development in the next ten years, and the market value of the two companies will definitely skyrocket to an absolute height at that time. Just like Lantian Company, which was only listed in October last year, although the issue price was very high, and it rose by nearly half on the day of listing, its stock price has been rising steadily in a few months, and with more new products being listed, the current market value has properly exceeded 100 billion Chinese dollars!

The question is, under the leadership of Tian Lu, will the creatures in the future always eat the old book?

This is also the reason why those financial institutions and multinational companies have been staring at Future Biotech and constantly advocating for it to be listed, such a scientific research institution with strong patent capital and super R&D capabilities is a super big fat in the eyes of everyone!

In fact, if the future of biology can be listed, it will inevitably set off a financial frenzy!

It's a pity that Tian Lu doesn't have the slightest idea of preparing to list Future Biology on the market, in his plan, Future Biology will inevitably attract foreign funds in the future, and it is a very large amount of money. But the way is definitely not achieved through listing, and it is absolutely impossible to introduce funds from abroad, otherwise, it would not be meaningful for him to choose to return to China to start a business。。。。。。。

。。。。。。

In May 2027, the Academy of Sciences and the Academy of Engineering successively announced the list of valid candidates for the co-election of academicians this year, Tian Lu's friend Feng Lin was on the list of candidates for the Academy of Engineering, and Huang Qiaoqiao's name was also on the list of co-opted academicians of the Academy of Sciences!

Naturally, this caused quite a stir!

β€œγ€‚γ€‚γ€‚γ€‚γ€‚γ€‚ Qiaoqiao is too young. ”

On the phone, Tian Lu smiled with some sighs: "I'm younger than when I was elected, hehe." This is the so-called blue out of the blue and better than the blue!"

"Teacher, you're laughing. It's probably because of Qiaoqiao standing on the shoulders of giants!"

Xia Ruo patted the teacher's ass lightly, and said with a smile.

Tian Lu smiled slightly, shook his head noncommittally, and said, "But in terms of results alone, there is definitely no problem for her to be elected." I don't think anyone would dare to dwell too much on this. The only downside is age and seniority. Hehe. But if the Academy of Sciences had me, it would definitely not have allowed seniority to overwhelm grades!"

Tian Lu's words were quite confident.

As an academician of the Academy of Sciences, Tian Lu's current prestige is enough to ensure that his students can receive absolutely fair treatment. Including Feng Lin from the Engineering Academy, it was the same, so after hearing the teacher's words, Xia Ruo also sighed with envy: "If the teacher is here, Qiaoqiao is indeed very lucky!"

"Haha, don't always envy her, you should be fast!"

Smiling, Tian Lu comforted Xia Ruo and said, "Your achievements in the field of blood-brain barrier alone are enough, but I personally suggest that you should wait for the current research topic to have phased results before mixing these things, so as not to distract yourself." Don't worry, as long as you have enough achievements to show your hands, the teacher will definitely help you!"

Of course, Tian Lu will not help him and the students to do anything as Feng Lin said, but if their achievements are obviously stronger than other candidates, he does not mind exerting his influence in the academic world, so that they can smoothly enter the Academy of Sciences and the Academy of Engineering. In fact, according to the current situation, Tian Lu is full of confidence that neurosurgery may be more difficult, but his students in the institute and Future Biology, including some very outstanding young researchers, will definitely become an important force in the Academy of Sciences in the future!

Tian Lu can almost foresee that in the future of Huaguo's neuroscience field, there will be a cutting-edge scientific and technological force called Tian Jiajun。。。。。。

After hanging up Xia Ruo's phone, Tian Lu first smiled slightly, and then immediately fell into deep thought.

It is undeniable that most of the students accepted by Tianlu over the years, whether it is the clinical and basic eight-year students of Beijing Normal University, or the master's students recruited from all over the country, are still very good. Although there are also Ling Feifei who chose the wrong direction, and there are a few who were abandoned by Tian Lu because of insufficient effort and other factors, most of them are very good, and now they have become the mainstay of other units like Xia Ruo, or they still play a huge role under Tian Lu!

Huang Qiaoqiao and Xia Ruo are just the earliest leaders.

But Tian Lu also understands one thing, that is, these students, in some aspects, may not necessarily be their best helpers in the future!

After all, it was cultivated by traditional education, and at least at the undergraduate level, Tian Lu had never intervened.

"So, should you start preparing now?"

His brows suddenly furrowed, and Tian Lu began to think seriously: "It's not too early, perhaps, I should discuss with Fei Li, and establish a Tian Jiajun who has been clearly branded since graduating from high school。。。。。。 ”

。。。。。。。。。。。。。。。。。。。。。。。。。。。。。。

Today's first chapter.

There are not many plots left in the future, and this kind of book becomes more difficult to write the further it goes, and there are too many things to think about in the future. And it's nothing more than a repeat of making money, producing results, and winning awards, which doesn't make much sense. As for the other regular urban plots, I don't plan to write this book, and I'm going to keep it that way until the end.

I'll write as much as I can in December and try to end the story. So it's basically the last month of the book.

Except for the one time on the shelves, ask for a ticket again before finishing the book.

If you don't ask for a whole month, you want a day, a monthly pass and a recommended ticket, and I want to see how many people are still 。。。。。。 Well, I'm still following this book today, haha!

In addition, quietly ask for a first order.,It's just a few dozen to five thousand.,Let this book make up a whole number.,Okay?(To be continued.) )